Nicolás Isambert

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Advanced Cancer, Drug Targeting, Oncology +12

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

Nicolas Penel, Binh Bui, Jacques‐Olivier Bay et al. · Journal of Clinical Oncology · 2008 · 683 citations · Full text

Improved survival using specialized multidisciplinary board in sarcoma patients

Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel et al. · Annals of Oncology · 2017 · 349 citations · Full text

Surgical Oncology, Specialized Multidisciplinary Board, Medicine +5

Heterocycles as Key Substrates in Multicomponent Reactions: The Fast Lane towards Molecular Complexity

Nicolás Isambert, Rodolfo Lavilla · Chemistry - A European Journal · 2008 · 317 citations

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nicolas F. Delahaye, Sylvie Rusakiewicz, Isabelle Martins et al. · Nature Medicine · 2011 · 315 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +8